Press Releases
Safe Bulkers, Inc. Declares Quarterly Dividend on its 8.00% Series C Cumulative Redeemable Perpetual Preferred Shares; 8.00% Series D Cumulative Redeemable Perpetual Preferred Shares
MONACO, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Safe Bulkers, Inc. (the “Company”) (NYSE/Euronext Athens: SB), an international provider of marine drybulk transportation services, announced today that the Company's Board of Directors has declared:
PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.0833 per Share
MIAMI, Oct. 02, 2026 (GLOBE NEWSWIRE) -- PennantPark Floating Rate Capital Ltd. (the "Company") (NYSE: PFLT) declares its monthly distribution for October 2026 of $0.0833 per share, comprised of an $0.08 per share base dividend and $0.0033 per share supplemental dividend, payable on November 2, 2026 to stockholders of record as of October 15, 2026. The distribution is expected to be paid from taxable net investment income. The final specific tax characteristics of the distribution will be reported to stockholders on Form 1099 after the end of the calendar year and in the Company's periodic report filed with the Securities and Exchange Commission...
Rush Enterprises, Inc. Conference Call Advisory for Third Quarter 2026 Earnings Call
NEW BRAUNFELS, Texas, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Rush Enterprises, Inc., (NASDAQ: RUSHA & RUSHB), which operates the largest network of commercial vehicle dealerships in North America will host a conference call to discuss earnings for the third quarter 2026 on Wednesday, October 28, 2026 at 10:00 a.m. Eastern/9:00 a.m...
Spyre Therapeutics Announces Grants of Inducement Awards
WALTHAM, Mass., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology company committed to developing next-generation therapies that elevate the standard in immunology by delivering more complete disease control, greater durability, and a simpler treatment experience for patients, today announced that Spyre's independent Compensation Committee of the Board of Directors approved the grant of stock options to purchase an aggregate of 21,424 shares of common stock of Spyre and 6,604 restricted stock units (“RSUs”) to two non-executive employees as equity inducement awards under the Spyre Therapeutics, Inc. 2018 Equity Inducement Plan, as amended (the “2018 Plan”). The stock options and RSUs were approved on October 1, 2026 and were material to each employee's acceptance of employment with Spyre, in accordance with Nasdaq Listing Rule 5635(c)(4)...
Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Apnimed, Inc. (Nasdaq: APMD) (“Apnimed” or the “Company”), a late-stage clinical pharmaceutical company dedicated to the discovery, development and commercialization of novel oral therapies that address the neurobiology of sleep-related breathing diseases, today announced that on October 1, 2026, the compensation committee of Apnimed's board of directors granted 19 new non-executive employees non-qualified stock options to purchase an aggregate of 481,300 shares of the Company's common stock under Apnimed's 2026 Inducement Plan (the “Plan”). Each stock option granted has an exercise price per share of $22.54, which is equal to Apnimed's closing trading price on the grant date. One-fourth of the shares underlying each of the employee's stock options will vest on the first anniversary of each employee's start date and in equal monthly installments thereafter for the next three years, subject to such employee's continued employment with the Company on such vesting dates...
PennantPark Investment Corporation Announces Monthly Distribution of $0.08 per Share
MIAMI, Oct. 02, 2026 (GLOBE NEWSWIRE) -- PennantPark Investment Corporation (the "Company") (NYSE: PNNT) declares its monthly distribution for October 2026 of $0.08 per share, comprised of a $0.04 per share base dividend and $0.04 per share supplemental dividend, payable on November 2, 2026 to stockholders of record as of October 15, 2026. The distribution is expected to be paid from taxable net investment income. The final specific tax characteristics of the distribution will be reported to stockholders on Form 1099 after the end of the calendar year and in the Company's periodic report filed with the Securities and Exchange Commission...
Covenant Logistics Group, Inc. Announces Timing of Third Quarter Earnings Release and Conference Call
CHATTANOOGA, Tenn., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Covenant Logistics Group, Inc. (NYSE: CVLG) announced its plans to release its third quarter earnings after 4:00 p.m. Eastern time on Thursday, October 29, 2026. Covenant Logistics Group, Inc. will hold a live conference call to discuss its third quarter earnings release on Friday, October 30, 2026, at 10:00 a.m. Eastern time. Individuals with questions may dial in at 877-550-1505 (U.S./Canada) and 0800-524-4760 (International). An audio replay will be available for one week following the call at 800-645-7964, access code 3895#. In addition, you will be able to listen to the audio replay for an extended period of time on our investor website, under the icon "Audio Archives". For additional financial and statistical information regarding the Company that may be discussed during the conference call, please visit our website at www.covenantlogistics.com/investors under “Earnings Info.”
WISeQey's Subsidiary WISeSat.Space, a Space Technology Company, Completes Business Combination with Columbus Acquisition Corporation
WISeQey's Subsidiary WISeSat.Space, a Space Technology Company, Completes Business Combination with Columbus Acquisition Corporation
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BRISBANE, Calif., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on September 29, 2026, the Compensation Committee of the Board of Directors (Compensation Committee) of Vera Therapeutics granted inducement awards consisting of non-qualified stock options to purchase 16,700 shares of Class A common stock and restricted stock units (RSUs) underlying 8,350 shares of Class A common stock to five (5) new employees under the Inducement Plan...
Aardvark Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, today announced that on October 1, 2026, one new employee was granted an inducement award consisting of a stock option to purchase 60,000 shares of common stock...
Integer Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028
PLANO, Texas, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) (“Integer” or the “Company”), a leading medical device contract development and manufacturing organization, today notified holders of its 2.125% Convertible Senior Notes due 2028 (the “Notes”) that the Notes are convertible, at the option of the holders (the “Conversion Option”) beginning on October 1, 2026, and ending at the close of business on December 31, 2026. The Notes are convertible into cash, up to the principal amount of the Notes, and in cash, shares of the Company's common stock or a combination thereof, at the Company's election, in respect of the remainder, if any, of the Company's conversion obligation in excess of the aggregate principal amount of the Notes being converted...
Pasqal Appoints Roger L. Chuchen as Head of Investor Relations
PARIS and NEW YORK, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Pasqal (NASDAQ: PSQL), a global leader in neutral-atom quantum computing, today announced the appointment of Roger L. Chuchen as Head of Investor Relations, as the company expands its commercial operations and global customer base following its Nasdaq listing in August 2026...
PetMeds Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
DELRAY BEACH, Fla., Oct. 02, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx (Nasdaq: PETS), today announced that PetMeds recently granted equity awards previously approved by its Board of Directors to two newly hired executives as a material inducement to employment...
Allison Completes Partial Redemption of 4.750% Senior Notes due 2027
INDIANAPOLIS, Oct. 2, 2026 /PRNewswire/ -- Allison Transmission Holdings, Inc. (NYSE: ALSN) ("Allison" or the "Company") announced the completion of its partial redemption of $100 million aggregate principal amount of its 4.750% Senior Notes due 2027 (the "notes") on September 30, 2026 (the "redemption date"), pursuant to its optional redemption right under the indenture governing the notes, dated as of September 26, 2017. On the redemption date, the notes were redeemed at a redemption price of 100.00% of the principal amount thereof plus accrued and unpaid interest to, but not including, the redemption date...
Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced the grant of inducement equity awards to five newly hired non-executive employees as a material inducement to commencing their employment with the Company. The employees received, in the aggregate, non-qualified stock options to purchase 86,725 shares of Monte Rosa Therapeutics common stock, par value $0.0001 per share, with an exercise price per share equal to the closing price of $11.26 as reported by Nasdaq on October 1, the effective date of the grant or the “Grant Date”, which will vest 25% on the first anniversary of the Grant Date and in 36 equal monthly installments thereafter, subject to the employee's continued service with the Company through each applicable vesting date; and restricted stock units for an aggregate of 19,150 shares of Monte Rosa Therapeutics common stock, which will vest 25% on each of the first four anniversaries of the Grant Date, subject to the employee's continued service with the Company through each applicable vesting date, or collectively, the Awards...
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
VANCOUVER, BC and BOSTON, MA, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need, today announced equity inducement grants to eight new non-officer employees consisting of an aggregate of 17,850 share options and 10,500 restricted share units (RSUs). All of the foregoing share options and RSUs were approved by the Compensation Committee of the Company's Board of Directors with an effective date of October 1, 2026 and were granted as inducements material to the employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4)...
Teknova and Pluristyx Announce FDA Drug Master File for the PluriFreeze™ Cryopreservation System
Teknova and Pluristyx announce a Type II FDA Drug Master File for the PluriFreeze™ cryopreservation system, now available to developers for cross-reference
Carlsmed, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CARLSBAD, Calif., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced that on September 28, 2026, it granted stock options to purchase 180,137 shares of the Company's common stock and 89,286 time-based restricted stock units (“RSUs”) to Richard Heppenstall, the Company's newly-hired Chief Financial Officer, as a material inducement to his employment...
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NAARDEN, The Netherlands and MIAMI, Oct. 02, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that the Compensation Committee of NewAmsterdam's Board of Directors approved the grant of inducement share options covering an aggregate of 71,800 of NewAmsterdam's ordinary shares to 7 non-executive new hires. The share options were granted as an inducement material to the employees' acceptance of employment with NewAmsterdam pursuant to the NewAmsterdam Pharma Company N.V. 2024 Inducement Plan (the “2024 Inducement Plan”) and in accordance with Nasdaq Listing Rule 5635(c)(4)...
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced that on October 1, 2026, the Compensation Committee of Praxis' Board of Directors granted restricted stock unit awards covering an aggregate of 3,478 shares of its common stock to fourteen new non-executive employees under the Praxis Precision Medicines, Inc. 2024 Inducement Plan (the 2024 Inducement Plan). The restricted stock unit awards were granted as inducements material to the employees' entering into employment with Praxis in accordance with Nasdaq Listing Rule 5635(c)(4)...
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
NEW YORK, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on October 1, 2026, the Company granted inducement awards to purchase up to 213,300 shares of common stock to nine new employees under the Company's 2023 Inducement Plan. The stock options will vest over four years, with 25% of the underlying shares vesting on the one-year anniversary of the vesting commencement date and 1/48th of the underlying shares vesting monthly thereafter over 36 months, subject to the employee's continued service relationship with Syndax through the applicable vesting dates...
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies, today announced that on October 1, 2026, it awarded inducement grants to eight new employees under Intellia's 2024 Inducement Plan, as amended, as a material inducement to employment...
Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WILMINGTON, Del., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), today announced that the Company granted non-qualified stock options to purchase up to an aggregate of 128,000 shares of the Company's common stock to two newly-hired non-executive employees under the Company's 2026 Inducement Equity Plan (the “Inducement Plan”), effective as of September 30, 2026 (the “Effective Date”). The inducement grants were previously approved by the Compensation Committee of the Company's Board of Directors, as a material inducement to the new employees' entry into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4)...
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WESTLAKE VILLAGE, Calif., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced the grant of an aggregate of 62,500 restricted stock units (RSUs) of Arcutis common stock to six newly hired employees. These awards were approved by the Compensation Committee of Arcutis' Board of Directors and granted under the Arcutis Biotherapeutics, Inc. 2022 Inducement Plan, with a grant date of October 1, 2026, as a material inducement to the new employees in connection with their commencement of employment with Arcutis, in accordance with Nasdaq Listing Rule 5635(c)(4)...
EPAM Announces Date for Third Quarter Earnings Release and Conference Call
NEWTOWN, Pa., Oct. 2, 2026 /PRNewswire/ -- EPAM Systems, Inc. (NYSE: EPAM), a leading digital transformation services and product engineering company, will host a conference call at 8:00 a.m.
Equity Bancshares, Inc. Will Announce Third Quarter 2026 Results on October 14, 2026
WICHITA, Kan.--(BUSINESS WIRE)--Equity Bancshares, Inc. (NYSE:EQBK), (“Equity”), the Wichita-based holding company of Equity Bank, will release its third quarter financial results on Wednesday, October 14, 2026, with a press release issued after market close. Equity Chairman and Chief Executive Officer Brad Elliott, Equity Bank Chief Executive Officer Rick Sems and Chief Financial Officer Chris Navratil will hold a conference call and webcast to discuss earnings results on Thursday, October 15,...
Advanced Gold Signs MOU to Acquire Corcoran Silver Gold Property with Historical Inferred Silver Resource
Vancouver, British Columbia--(Newsfile Corp. - October 2, 2026) - Advanced Gold Exploration Inc. (CSE: AUEX) (FSE: ZF2) (OTCQB: AUHIF) ("Advanced Gold" or the "Company") is pleased to announce that it has executed a memorandum of understanding on September 30, 2026 (the "MOU") with Ameerex Corporation (OTCID: HIRU) ("Ameerex"). Under the MOU, the Company will assume Ameerex's rights and obligations to acquire 100% of North American Silver Corporation ("NAS") and, indirectly, Centennial Mining ("CM") from Electric Metals (USA) Limited ("EML")...
Kaplan Fox Reminds Tigo Energy, Inc. (TYGO) Investors with Significant Losses to Seek a Leadership Role Before Deadline on November 23, 2026
New York, New York--(Newsfile Corp. - October 2, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Tigo Energy, Inc. ("Tigo Energy" or the "Company") (NASDAQ: TYGO) on behalf of investors that purchased or otherwise acquired Tigo Energy securities between February 24, 2026 and August 4, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in Tigo Energy and have suffered losses, you may CLICK HERE to contact us...
Horizon Bancorp, Inc. Announces Conference Call to Review Third Quarter Results on October 22
MICHIGAN CITY, Ind., Oct. 02, 2026 (GLOBE NEWSWIRE) -- (NASDAQ GS: HBNC) – Horizon Bancorp, Inc. (“Horizon” or the “Company”) will host a conference call at 7:30 a.m.
Good Sports and TruGreen Host 'Play Day Celebration' and Equipment Donation to Kick off Fall Sports Season at Local High School
TruGreen and iHeartMedia announce national collaboration to support youth sports, including a celebratory equipment donation and 'Play Day' with Maplewood High School FRANKLIN, Tenn., Oct. 2, 2026 /PRNewswire/ -- TruGreen, in collaboration with Good Sports and iHeartMedia, announced an initiative to help further Good Sports' mission to drive equitable access in youth sports and physical activity by supporting children in high-need communities to achieve their greatest potential, on the field and in life...
Bayer to Invest 2.2 Billion U.S. Dollars in a New Manufacturing Site in the United States
NEW ALBANY, Ohio--(BUSINESS WIRE)--Bayer announced on Friday plans to invest 2.2 billion U.S. dollars in a new pharmaceutical manufacturing site in New Albany, Ohio, U.S. Building on more than seven billion dollars in U.S. pharma R&D and manufacturing spend over the past five years, the project is a central element of Bayer's long-term growth strategy and commitment to innovation and patient access in its largest pharmaceuticals market. “Bayer has long seen the United States as a key manufa...
Lilly's Jaypirca (pirtobrutinib), the first-and-only approved non-covalent BTK inhibitor, receives expanded indication from U.S. FDA for certain patients with previously untreated CLL/SLL
INDIANAPOLIS, Oct. 2, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved an additional indication for Jaypirca (pirtobrutinib, 100 mg & 50 mg tablets), a non-covalent Bruton tyrosine kinase (BTK) inhibitor, for the treatment of adult patients with previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) with no known 17p deletion. This approval allows for the use of Jaypirca as a first-line treatment for appropriate patients...
Awayday Announces Strategic Investment from Warburg Pincus
Investment reinforces Awayday's locally-run, field-first model and supports its commitment to delivering value to key stakeholders DESTIN, Fla., Oct. 2, 2026 /PRNewswire/ -- Awayday (the "Company"), a leading vacation rental management company on a mission to perfect the vacation rental experience for owners and guests alike, today announced it has closed a significant investment from Warburg Pincus, the pioneer of global growth investing...
Gray Sets Date for Third Quarter Earnings Release and Earnings Conference Call
ATLANTA, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Gray Media, Inc. (NYSE: GTN) today announced that it will release its earnings results for the quarter ending September 30, 2026, on Friday, November 6, 2026.
Emera Announces Increase in Common Dividend
HALIFAX, Nova Scotia--(BUSINESS WIRE)--Emera Inc. (TSX/NYSE: EMA) today announces that its Board of Directors have approved an increase in the company's quarterly dividend on its common share to $0.74 per share. The new quarterly dividend represents an annualized dividend of $2.96, a 1% increase from the previous annual dividend of $2.93 per share. “This increase marks our 20th consecutive year of dividend growth, underscoring the strength of our business and our commitment to delivering stable...
SMX: The Age of Parity is Permanent - and Certified Recycled Plastic Has Emerged as Its Economic Outcome
NEW YORK CITY, NY / ACCESS Newswire / October 2, 2026 / The Age of Parity is permanent, and certified recycled plastic has emerged as one of its most important economic solutions. As war, oil volatility, tariffs, trade fragmentation and supply-chain nationalism alter the global economy, manufacturing with certified recycled plastic is no longer simply an environmental preference...
ALIF Holding Breaks Ground on Phase I of Umm Al Quwain Industrial Park
UMM AL QUWAIN, United Arab Emirates, Oct. 02, 2026 (GLOBE NEWSWIRE) -- ALIF Holding, the industrial group of Robo.ai (Nasdaq: AIIO), held the groundbreaking ceremony for Phase I of the ALIF Holding Group Industrial Park in Umm Al Quwain on September 25.
2026 Regular-Season Champion Matt Hagan Carries NHRA Points Lead into St. Louis in American Rebel Light Beer Funny Car
WIN HAGAN WIN! WIN REBEL LIGHT WIN!
Viridian Intersects Sulphides Throughout 3 km of Step-Out Drilling at Kraken Main
Viridian intersects visual sulphides in all 8 step-out holes across 3 km at Kraken Main, Labrador; also engages Oak Hill and achieves DTC eligibility
Epic Gold Closes Its Non-Brokered Private Placement
Toronto, Ontario--(Newsfile Corp. - October 2, 2026) - Epic Gold Corp. (CSE: EPG) (OTCQB: NFLDF) (FSE: 6340) ("Epic Gold" or the "Company") is pleased to announce that it has closed its non-brokered private placement previously announced on September 4, 2026. The Company has issued 22,200,000 units at a price of $0.14 per unit for proceeds of $3,108,000...
KBRA Assigns Preliminary Ratings to GSTAR 2026-FL1
NEW YORK--(BUSINESS WIRE)-- #creditratingagency--KBRA is pleased to announce the assignment of preliminary ratings to eight classes of GSTAR 2026-FL1, a managed CRE CLO securitization with the ability to reinvest principal proceeds for 30 months. The transaction will initially be collateralized by 22 mortgage loans with an aggregate cutoff date in-trust balance of $1.025 billion. Additionally, the transaction provides the sponsor with the ability to effectuate modifications to performing loans, as well as buy out de...
MicroVision Updates Start Time for Video Session & Business Update on October 7, 2026
REDMOND, WA / ACCESS Newswire / October 2, 2026 / MicroVision, Inc. (NASDAQ:MVIS), a leader in advanced perception solutions for industrial, security and defense, and automotive applications, today provided an updated time for its previously announced video-enabled discussion and business update hosted by Company leadership on Wednesday, October 7, 2026. The session will now begin at 4:00 PM ET...
APFC Holds Annual Meeting of the Board of Trustees in Nome
NOME, Alaska--(BUSINESS WIRE)--The Alaska Permanent Fund Corporation's (APFC) Board of Trustees convened its Annual Meeting on September 30 and October 1, 2026, in Nome and online. Trustees reviewed Fiscal Year (FY) 2026 Fund performance, received an in-depth review of the Real Estate portfolio, adopted an updated Investment Policy Statement, and established a Benchmark Review Committee. As part of its annual governance responsibilities, the Board also elected its corporate officers, reelecting...
Kaplan Fox Advises AST SpaceMobile, Inc. (ASTS) Investors to Act Before the Lead Plaintiff Deadline on November 13, 2026
New York, New York--(Newsfile Corp. - October 2, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against AST SpaceMobile, Inc. ("AST" or the "Company") (NASDAQ: ASTS) on behalf of investors that purchased or otherwise acquired AST securities between March 4, 2025 and July 15, 2026 (the "Class Period"). CLICK HERE TO JOIN THE CASE If you are an investor in AST and have suffered losses, you may CLICK HERE to contact us...
Chaince Securities, LLC to Serve as Exclusive Sales Agent for Magic Empire Global Limited's (NASDAQ: MEGL) US$100 Million At-the-Market Offering Program
New York, NY, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Chaince Securities, LLC (“Chaince”), a FINRA-registered broker-dealer and wholly owned subsidiary of Chaince Digital Holdings Inc. (NASDAQ: CD), today announced that it has been engaged as the exclusive sales agent for the at-the-market (“ATM”) equity offering program of Magic Empire Global Limited (NASDAQ: MEGL) (the “Company”), a British Virgin Islands-incorporated holding company whose operations are conducted in Hong Kong through its operating subsidiaries and which is principally engaged in corporate finance advisory services. The engagement is made pursuant to an At-the-Market Offering Agreement dated September 30, 2026 (the “Sales Agreement”), under which the Company may offer and sell, from time to time, Class A ordinary shares of the Company (the “Shares”) having an aggregate offering price of up to US$100 million through Chaince, as sales agent...
Independent Inspector Provides Preliminary Report Substantiating that Garg Group Has Over 52% of the Votes Required to Forcibly Remove Daniel Lewis, Harit Talwar and Three Other Directors from Better Board
NEW YORK--(BUSINESS WIRE)--First Coast Results Inc., an independent election inspector hired by the Company to verify election results, confirmed yesterday that it had provided preliminary verification that the votes obtained by the Garg Group to remove five incumbent directors from the Board of Directors (the “Board”) of Better Home & Finance Corporation ("Better" or the "Company") (Nasdaq: BETR) exceeded 52%. The inspector's preliminary vote count is subject to review by the Company. The...
CUPE 2484 members at Ideal Child Service Group preparing to strike Monday
TORONTO--(BUSINESS WIRE)--Child care workers at Ideal Child Service Group (ICSG) represented by CUPE Local 2484 are preparing to be on strike as of Monday, October 5 if the employer does not return to the bargaining table to negotiate a fair collective agreement. The workers provide essential care and education to children at five ICSG locations across Toronto. They are fighting for fair wages, better working conditions and the resources they need to deliver quality child care. “Our members wou...
Kaplan Fox is Investigating Claims Against The Ensign Group, Inc. (ENSG) on Behalf of Investors
New York, New York--(Newsfile Corp. - October 2, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against The Ensign Group, Inc. ("Ensign" or the "Company") (NASDAQ: ENSG). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are an Ensign investor and have suffered losses, or if you have information that could assist in the Ensign investigation, you may CLICK HERE to contact us...
Eurofins Scientific SE: Director/PDMR Shareholding
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM 1. Details of the person discha...
CEO.CA's Inside the Boardroom: Grid Metals Delivers "Globally Significant" Cesium Resource Estimate
Toronto, Ontario--(Newsfile Corp. - October 2, 2026) - CEO.CA ("CEO.CA"), the leading investor social network in junior resource and venture stocks, shares exclusive updates with CEOs of junior mining explorers. Founded in 2012, CEO.CA, a wholly owned subsidiary of EarthLabs, Inc. , is one of the most popular free financial websites and apps in Canada and for investors globally - with industry leading audience engagement and mobile functionality...
HII Promotes Greg Ennis to Chief Financial Officer of Mission Technologies
MCLEAN, Va., Oct. 02, 2026 (GLOBE NEWSWIRE) -- HII (NYSE: HII) announced today that Greg Ennis has been promoted to senior vice president and chief financial officer of its Mission Technologies division. In this role, Ennis will lead the division's financial organization and oversee accounting, financial reporting, financial planning and analysis, rates and budgets, and program cost control across the business...
LiveWire® S4 Honcho™ Meets Criteria for Motorcycle Safety Foundation® Rider Training Programs Opening a New Path Into Rider Training
MILWAUKEE--(BUSINESS WIRE)--LiveWire (NYSE: LVWR), a leader in the electric two-wheel industry, today announced that the S4 Honcho™ Street meets the Motorcycle Safety Foundation (MSF) criteria for use in rider training programs and will join the training lineup. This milestone represents a significant step forward in rider education and advances LiveWire's mission to make motorcycling more accessible and safer for a new generation of riders. As a new generation begins their mobility journeys on...
FuelCell Energy (FCEL) Securities Fraud: Contact Berger Montague To Discuss Your Rights
Philadelphia, Pennsylvania--(Newsfile Corp. - October 2, 2026) - Berger Montague, a leading national plaintiffs' law firm, announces that a class action lawsuit has been filed against FuelCell Energy, Inc. (NASDAQ: FCEL) ("FuelCell Energy" or the "Company") on behalf of investors who purchased or acquired FuelCell Energy securities during the period from June 24, 2026 through September 1, 2026 (the "Class Period"). The deadline to apply for lead plaintiff is November 10, 2026...
Standard Dental Labs Acquires Dr. Tooth Dental Lab
Sheen Dental and Hansen Incarnati join SDL as the Company plans to bring outsourced production to Sarasota Sheen Dental and Hansen Incarnati join SDL as the Company plans to bring outsourced production to Sarasota
Perspective Therapeutics Announces Acceptance of [212Pb]VMT01 Data for Presentation at SITC 2026
SEATTLE, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective,” the “Company,” “we,” “us,” and “our”) (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers throughout the body, today announced that data from the Company's lapemelanotide zapixetar (also known as [²¹²Pb]VMT01) program have been accepted for presentation at the Society for Immunotherapy of Cancer (SITC) 41st Annual Meeting & Pre-Conference Programs taking place November 4 to 8, 2026, in Phoenix, Arizona. SITC plans to release further details for regular abstracts on November 3, 2026...
PNC Declares Dividend of $2.00 on Common Stock
PITTSBURGH, Oct. 2, 2026 /PRNewswire/ -- The board of directors of The PNC Financial Services Group, Inc. (NYSE: PNC) declared a quarterly cash dividend on the common stock of $2.00 per share. The dividend will be payable Nov. 5, 2026, to shareholders of record at the close of business Oct. 14, 2026...
Biogen's Litifilimab Demonstrates Rapid and Durable Efficacy in New 52-Week Phase 2 Data from Ongoing Phase 2/3 AMETHYST Study, Reinforcing Its Potential as a First-in-Class Therapy for Cutaneous Lupus Erythematosus
CAMBRIDGE, Mass., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced 52-week results from the Phase 2 part of the ongoing AMETHYST Phase 2/3 study (Part A) of litifilimab in people living with cutaneous lupus erythematosus (CLE). The updated results, presented at the European Academy of Dermatology and Venereology (EADV) 2026 Congress in Vienna, Austria, represent the longest dataset reported for litifilimab in CLE and further support its potential to achieve rapid and durable improvements in skin disease activity. In the study, participants treated with litifilimab in the double-blind, placebo-controlled period showed continued clinical improvements in skin disease activity through Week 52. Notably, participants who switched from placebo to litifilimab treatment at Week 24 experienced a rapid onset of treatment effect as early as four weeks...
Pfizer's LITFULO Significantly Improved Facial and Total Body Repigmentation in Patients with Nonsegmental Vitiligo
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today presented results from two Phase 3 trials evaluating the efficacy and safety of LITFULO (ritlecitinib) as a once-daily oral treatment across a wide range of disease extent. In the two studies, TRANQUILLO 2 and TRANQUILLO, LITFULO 100 mg and 50 mg, respectively, significantly improved facial and total body repigmentation compared to placebo. These improvements were supported by patient-reported outcomes indicating reduced disease severity...
Applause and Progress Software to Discuss AI's Role in Accessibility Compliance at M-Enabling Summit 2026
BOSTON--(BUSINESS WIRE)-- #A11y--Applause, the global leader in managed software testing services and digital quality, today announced it will co-host a session with Progress Software at the 2026 M-Enabling Summit, the premier global gathering advancing digital accessibility and inclusive technology, taking place October 5-7 in Arlington, Virginia. Speakers William Reuschel, Inclusive Design Practice Lead, Applause and John McCartney, Senior Manager of User Experience, Progress ShareFile, will lead the...
BioMarin Announces Five-Year Phase 3 Data for POMBILITI® (cipaglucosidase alfa-atga) + OPFOLDA® (miglustat) at World Muscle Society Annual Congress
Long-term data reinforce durable efficacy and safety of POMBILITI + OPFOLDA in late-onset Pompe disease SAN RAFAEL, Calif., Oct. 2, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced new data evaluating the efficacy and safety of POMBILITI (cipaglucosidase alfa-atga) + OPFOLDA (miglustat) in late-onset Pompe disease (LOPD) were presented at the 31st Annual Congress of the World Muscle Society (WMS), in Hiroshima, Japan...
KBRA Assigns Preliminary Ratings to New Residential Mortgage Loan Trust 2026-NQM10 (NRMLT 2026-NQM10)
NEW YORK--(BUSINESS WIRE)-- #creditratingagency--KBRA assigns preliminary ratings to 10 classes of mortgage-backed notes from New Residential Mortgage Loan Trust 2026-NQM10 (NRMLT 2026-NQM10), a $494.0 million non-prime RMBS transaction sponsored by Rithm Capital Corp. (formerly New Residential Investment Corp.), a publicly traded (NYSE: RITM) real estate investment trust (REIT). The underlying mortgages in the subject pool were primarily originated by NewRez LLC (56.6%). In addition, all loans will be serviced by S...
Kaplan Fox Alerts Innventure, Inc. (NASDAQ: INV) Investors to an Approaching Lead Plaintiff Deadline on October 27, 2026
NEW YORK, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Innventure, Inc. (“Innventure” or the “Company”) (NASDAQ: INV) on behalf of investors that purchased or otherwise acquired Innventure securities between November 17, 2025 and August 13, 2026 (the “Class Period”). CLICK HERE TO JOIN THE CASE If you are an investor in Innventure and have suffered losses, you may CLICK HERE to contact us...
Kaplan Fox Alerts Hyliion Holdings Corp. (NYSE: HYLN) Investors to an Approaching Lead Plaintiff Deadline on October 27, 2026
NEW YORK, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hyliion Holdings Corp. (“Hyliion” or the “Company”) (NYSE: HYLN) on behalf of investors that purchased or otherwise acquired Hyliion securities between May 12, 2026 and June 23, 2026 (the “Class Period”). CLICK HERE TO JOIN THE CASE If you are an investor in Hyliion and have suffered losses, you may CLICK HERE to contact us...
The Age of Parity Makes Affordability Real
NEW YORK CITY, NY / ACCESS Newswire / October 2, 2026 / It was there all along. SMX is unlocking new economic value from the enormous supply of plastic the world has already manufactured, much of it sitting in products, packaging and waste streams across the global economy.
Broadway Star Morgan Dudley Returns to Stargaze Stage™ to Discover Broadway's Next Star
Submissions Now Open for the Morgan Dudley Broadway Challenge, Presented in Partnership with Eris Talent Agency Submissions Now Open for the Morgan Dudley Broadway Challenge, Presented in Partnership with Eris Talent Agency
CRISPR Therapeutics to Present Clinical Data on Zugocabtagene Geleucel (Zugo-cel) in Autoimmune Disease at the American College of Rheumatology (ACR) Convergence 2026
ZUG, Switzerland and BOSTON, Oct. 02, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), today announced that a poster presentation highlighting the Company's Phase 1 clinical data of its investigational CRISPR/Cas9 gene-edited allogeneic CAR T cell therapy, zugocabtagene geleucel (zugo-cel) targeting CD19 for autoimmune disease, will be presented at the American College of Rheumatology (ACR) Convergence 2026...
Hilton Grand Vacations Opens Ka Haku, a Hilton Club in Waikiki
HONOLULU--(BUSINESS WIRE)--Hilton Grand Vacations Inc. (NYSE: HGV), the premier vacation ownership and experiences company, today opened Ka Haku, a Hilton Club. Located in the heart of Waikiki, Ka Haku is the company's 14th resort in the state and the first Hilton Club-branded property in Hawaii, a distinction reserved for a boutique, highly curated ownership experience. The property offers 205 studios, one-, two- and three-bedroom suites with ocean, mountain and city views, along with an arriva...
Saba Opportunistically Hedged Closed-End Funds ETF (CEFS) Announces Changes to Distribution Rate and Frequency
Fund Will Move from Monthly to Quarterly Distributions OKLAHOMA CITY, Oct. 2, 2026 /PRNewswire/ -- Saba Opportunistically Hedged Closed-End Funds ETF (Cboe BZX: CEFS) (the "Fund") today announced changes to the rate and frequency of the Fund's distributions to shareholders, based on the recommendation of the Fund's sub-adviser, Saba Capital Management, L.P. ("Saba"). Effective September 25, 2026, the Fund will seek to pay distributions at an annualized rate of 12% of the Fund's net asset value ("NAV") and will pay distributions quarterly rather than monthly...
MANTL to Host Webinar with Grow Financial Federal Credit Union on Building a Connected Origination Journey That Drove 3X Volume Growth
Credit union leaders to share how Grow Financial reduced online account opening to under three minutes and is unifying deposit and loan origination with MANTL Point-of-Sale PLANO, Texas, Oct. 2, 2026 /PRNewswire/ -- Alkami Technology, Inc. (Nasdaq: ALKT) ("Alkami"), a digital sales and service platform provider for financial institutions in the U.S., today announced that MANTL will host a live webinar featuring Grow Financial Federal Credit Union (Grow Financial), highlighting how the credit union transformed account opening into a connected origination journey that supports member growth, operational efficiency, and deeper relationships. Hosted in partnership with Callahan & Associates, " 3X Growth with Accounts Opened in Under 3 Minutes: How Grow Financial Built One Connected Origination Journey " will take place on Monday, Oct. 5 at 2 p.m...
Kaplan Fox Alerts GoDaddy Inc. (NYSE: GDDY) Investors to an Approaching Lead Plaintiff Deadline on October 20, 2026
NEW YORK, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against GoDaddy Inc. (“GoDaddy” or the “Company”) (NYSE: GDDY) on behalf of investors that purchased or otherwise acquired GoDaddy common stock between September 3, 2025 and February 24, 2026 (the “Class Period”). CLICK HERE TO JOIN THE CASE If you are an investor in GoDaddy and have suffered losses, you may CLICK HERE to contact us...
Meet FORTITUDE™: The Single Chip Supercharging Data Speed and System Performance
A universal boost for today's systems that delivers the speed tomorrow's networks demand A universal boost for today's systems that delivers the speed tomorrow's networks demand
Kaplan Fox Notifies Beta Bionics, Inc. (NASDAQ: BBNX) Investors of an Upcoming Lead Plaintiff Deadline on November 3, 2026
NEW YORK, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NASDAQ: BBNX) on behalf of investors that purchased or otherwise acquired Beta Bionics common stock between July 30, 2025 and February 24, 2026 (the “Class Period”). CLICK HERE TO JOIN THE CASE If you are an investor in Beta Bionics and have suffered losses, you may CLICK HERE to contact us...
Travere to Present New Data Supporting FILSPARI® (sparsentan) as Foundational Treatment in IgA Nephropathy and FSGS at ASN Kidney Week 2026
SAN DIEGO--(BUSINESS WIRE)---- $TVTX--Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that it will share nine new data presentations, including five oral presentations, at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, CO, October 21-25. The presentations highlight compelling new data on FILSPARI (sparsentan) in patients with IgA nephropathy (IgAN) and focal segmental glomerulosclerosis (FSGS)."The final SPARTAN analysis provides a compelling picture of what's possible whe...
AIG to Report Third Quarter 2026 Financial Results on November 3, 2026, and Host Conference Call on November 4, 2026
NEW YORK--(BUSINESS WIRE)--American International Group, Inc. (NYSE: AIG) will report financial results for the third quarter ended September 30, 2026, after the market closes on Tuesday, November 3, 2026. AIG's press release and financial supplement will be available in the Investors section of AIG's website at https://www.aig.com. AIG will also host a conference call on Wednesday, November 4, 2026, at 8:30 a.m. ET to review these results. The live, listen-only webcast is open to the public an...
The Great Canadian Treasure Hunt Officially Enters Its Second Year with a New Regional Prize
Toronto, Ontario--(Newsfile Corp. - October 2, 2026) - EarthLabs Inc. (TSXV: SPOT) (OTCQX: SPOFF) (FSE: 8EK0) The Great Canadian Treasure Hunt is excited to announce a new regional prize, marking the official start of its second year. Organized by The Northern Miner, the treasure hunt encourages hunters and the broader public alike to explore Canada's incredible mining potential through project highlights alongside Canada's storied mining history...
KAYAK Unwraps the 2026 Holiday Travel Sweet Spots and Savings
Book now or wait? KAYAK's 2026 Holiday Travel Check-In uses historical fare trends to reveal the best times to buy and fly, plus where prices are falling this year NORWALK, Conn.
EMCOR Group, Inc. Declares Regular Quarterly Dividend
NORWALK, Conn.--(BUSINESS WIRE)--EMCOR Group, Inc. (NYSE: EME) today announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per common share. The dividend will be paid on October 30, 2026 to stockholders of record as of October 15, 2026. A Fortune 500 company and a member of the S&P 500, EMCOR Group, Inc. is a leader in mechanical and electrical construction services, industrial and energy infrastructure and building services. This press release and ot...
SeaStar Medical Announces Late-Breaking Presentation at ASN Kidney Week 2026
DENVER, Oct. 02, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure and potential loss of life announced today that a late-breaking abstract evaluating the results of the post-approval SAVE Registry data has been accepted for a special late-breaker poster presentation at the upcoming American Society of Nephrology (ASN) Kidney Week 2026 meeting, taking place in Denver, CO, October 21 – 25, 2026...
WesBanco, Inc. to Host 2026 Third Quarter Earnings Conference Call and Webcast on Thursday, October 22nd
WHEELING, W.Va., Oct. 2, 2026 /PRNewswire/ -- WesBanco, Inc. (Nasdaq: WSBC), a diversified, multi-state bank holding company, announced today it will host a conference call at 3:00 p.m.
First Financial Bancorp to Announce Third Quarter 2026 Financial Results on Tuesday, October 27, 2026
CINCINNATI, Oct. 2, 2026 /PRNewswire/ -- First Financial Bancorp. (Nasdaq: FFBC) announced today that it expects to release third quarter 2026 financial results after the market close on Tuesday, October 27, 2026.
Climb Bio to Present New Data at American Society of Nephrology (ASN) Kidney Week 2026 for CLYM116 and Budoprutug
Preliminary Phase 2 data from the ongoing PrisMN study of budoprutug in primary membranous nephropathy selected for oral presentation
Matador Technologies Provides Corporate Update and Reports Approximately 168 Bitcoin Held
Corporate update on capital structure, operational milestones, and governance developments since the beginning of its 2026 fiscal year on November 1, 2025
Kentucky American Water Now Accepting Applications for 2026 Firefighting Support Grants
Program has provided nearly $120,000 in grants since 2011 LEXINGTON, Ky., Oct. 2, 2026 /PRNewswire/ -- To reaffirm its longstanding support for local fire departments, Kentucky American Water today announced it is accepting applications for its 15th annual Firefighting Support Grant Program.
newcleo plc Reports First Half 2026 Financial and Operational Results
First Half 2026 and Subsequent Commercial and Operational Highlights Completed business combination with NewHold Investment Corp III (“SPAC”) on September 21, 2026 (the “Business Combination”); newcleo's ordinary shares and warrants commenced trading on the Nasdaq Global Select Market on September 22, 2026 under the symbols “NWCL” and “NWCLW,” respectively The Business Combination generated gross proceeds of approximately $247 million, consisting of approximately $31 million released from the SPAC's trust account and $216 million from the PIPE financing Raised approximately $18.7 million in additional financing unrelated to the Business Combination since May 2026, bringing total funds raised since newcleo's founding to over $1 billion Installed the main vessel and turbine for its PRECURSOR non-nuclear 10 MWt demonstration reactor at the ENEA Brasimone Research Center outside Bologna, Italy; completion of construction for PRECURSOR is expected by the end of 2026, with at-scale validation of systems to commence thereafter In partnership with Oklo, selected by the U.S. Department of Energy for advanced negotiations under the Surplus Plutonium Utilization Program Submitted Regulatory Engagement Plans to the U.S. Nuclear Regulatory Commission for the Company's LFR-AS-200 lead-cooled fast reactor and its planned U.S. mixed-oxide (MOX) fuel manufacturing facility Received notice of an overall opinion of satisfactory compliance from the French Nuclear Safety and Radiation Protection Authority for the proposed safety features for the Company's planned MOX fuel manufacturing facility in France Announced the acquisition, subject to customary closing conditions, of Bonifait Pesage, a French manufacturer of nuclear-grade scales and precision industrial weighing equipment, augmenting the Company's vertically integrated capabilities Announced the appointment of Jeffrey Lyash, a nuclear industry veteran and former head of the Tennessee Valley Authority, as Chairman of the Board of Directors Announced the appointment of William D. Magwood as Vice-Chairman of newcleo's Board of Directors, effective January 1, 2027 Announced the hiring of Dustin Greenwood as Vice President of U.S. Operations and Travis Chapman as Director of U.S. Regulatory Affairs and Licensing, strengthening the Company's growing U.S. team Announced a partnership with SHINE to assess and jointly pursue opportunities relating to nuclear fuel recycling in the United States and European Union On September 10, 2026, newcleo held an Analyst and Investor Day, a recording of which is available on newcleo's website First Half 2026 Financial Highlights Generated Revenue from Products and Services of approximately €19.4 million, an increase of approximately 46% over First Half 2025 Reported Net Loss of approximately €82.0 million, an increase of approximately 10% over First Half 2025 Reported Tangible Capital Expenditures of €25.3 million, an increase of 37% over First Half 2025 Reported Selling, General & Administrative expenses of €59.2 million, an approximately 21% increase over First Half 2025 Cash & Cash Equivalents as of June 30, 2026 stood at €66.5 million Total ordinary shares outstanding as of the closing date of the Business Combination stood at 281,534,950 As of September 30, 2026, preliminary, unaudited Cash & Cash Equivalents for the Company stood at approximately €233 million LONDON, Oct. 02, 2026 (GLOBE NEWSWIRE) -- newcleo plc (Nasdaq: NWCL) (“newcleo” or the “Company”), a pioneer in advanced modular reactor (“AMR”) technology and nuclear fuel manufacturing, today announced its operational and financial results for the six months ended June 30, 2026...
Vera Therapeutics Announces ORIGIN 3 Final Efficacy Analysis of TRUTAKNA™ (atacicept-vymj) in IgA Nephropathy Will be A Featured Late-breaking Oral Presentation at the Opening Plenary Session of ASN Kidney Week 2026
ORIGIN 3 Final Efficacy Analysis of TRUTAKNA™ (atacicept-vymj) in IgAN Will be A Featured Late-breaking Oral Presentation at Opening Plenary of ASN 2026
Decent Holding Inc. Announces Pricing of $1.23 Million Follow-on Offering
YANTAI, China, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Decent Holding Inc. (NASDAQ: DXST) (the “Company”), a technology-driven provider of wastewater treatment and community-based senior health and elderly care services in China today announced that it has entered into a securities purchase agreement (the “Securities Purchase Agreement”) with an institutional investor for the sale of (i) in a registered direct offering, 822,828 Class A ordinary shares, par value of $0.0025 per share, of the Company (the “Class A Ordinary Shares”) or, in lieu thereof, pre-funded warrants, at a purchase price of $1.50 per share; and (ii) in a concurrent private placement, unregistered warrants (the “Unregistered Warrants”) to purchase up to 822,828 Class A Ordinary Shares, with an exercise price of $1.50 per share (together, the “Securities”)...
Versant Reaches Multi-Year Distribution Renewal Agreement With Verizon
NEW YORK--(BUSINESS WIRE)--Versant (Nasdaq: VSNT) today announced it has reached a multi-year renewal of their distribution agreement with Verizon. The long-term agreement will continue to make Versant's portfolio of iconic brands, including USA Network, MS NOW, CNBC, Oxygen True Crime, Golf Channel, E!, and SYFY available to Verizon customers. With the completion of the Verizon agreement, Versant has successfully renewed all distribution partnerships expiring in 2026. “Verizon is a valued dist...
CJ CheilJedang and ADM to Form New Joint Venture to Strengthen Amino Acid Production and Supply Chains
CHICAGO & SEOUL--(BUSINESS WIRE)--CJ CheilJedang (CJ, KRX: 097950), a global food and biotech company that owns a leading animal nutrition business (known as CJ Bio), and ADM (NYSE: ADM), a global leader in innovative solutions from nature, have agreed to form a new joint venture to secure a reliable, long-term source of feed-grade amino acids critical to the livestock industry, strengthening U.S. production, global supply chain resilience and U.S. food security. “By combining CJ's industry-lea...
Moog and Niron Magnetics to Showcase Rare-Earth-Free Motor Technology at AUSA 2026
WASHINGTON, Oct. 2, 2026 /PRNewswire/ -- Moog Inc. (NYSE: MOG.A and MOG.B) and Niron Magnetics, the company commercializing the world's only high performance rare-earth-free Iron Nitride permanent magnets, will exhibit together at the Association of the United States Army (AUSA) 2026 Annual Meeting and Exposition, October 12–14, at the Walter E. Washington Convention Center in Washington, D.C. Attendees can visit the companies at Moog Booth #1947 to learn about their joint effort for rare-earth-free actuator solutions for land vehicles, guided munitions and other Army applications...
Cable One In Advanced Discussions Regarding Financing Transactions
PHOENIX--(BUSINESS WIRE)--Cable One, Inc. (NYSE: CABO) (“Cable One” or the “Company”) today announced it is in advanced discussions with GTCR LLC (“GTCR”), certain of its existing lenders and a consortium of leading private lending institutions regarding financing transactions to address certain of the Company's forthcoming capital needs. Cable One is working towards enhancing its capital structure to position the company to drive growth in shareholder value. “We are pleased at the momentum and...